06:46 AM EDT, 07/17/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) reported Q2 adjusted earnings Wednesday of $2.82 per diluted share, up from $2.56 a year earlier.

Analysts polled by Capital IQ expected $2.70.

Net sales for the quarter ended June 30 was $22.45 billion, up from $21.52 billion.

Analysts surveyed by Capital IQ expected $22.34 billion.

The company lowered its full-year adjusted earnings forecast to between $9.97 and $10.07 from the previous range of $10.57 to $10.72 in April. Analysts surveyed by Capital IQ expect $10.29.

JNJ shares fell 1.5% in premarket trading.

Price: 149.66, Change: -1.35, Percent Change: -0.89